Cocrystal Pharma (COCP) News Today → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free COCP Stock Alerts $1.95 -0.15 (-7.14%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 11:49 AM | finance.yahoo.comCOCP: Enrollment Complete in Phase 2a Human Challenge Trial of CC-42344…May 16 at 5:48 AM | americanbankingnews.comCocrystal Pharma (NASDAQ:COCP) Rating Reiterated by HC WainwrightMay 13 at 2:33 PM | investorplace.comCOCP Stock Earnings: Cocrystal Pharma Beats EPS for Q1 2024May 13 at 8:00 AM | globenewswire.comCocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development ProgramsMay 1, 2024 | finance.yahoo.comEnrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal InfluenzaMay 1, 2024 | globenewswire.comEnrollment Completed in Phase 2a Study with Cocrystal Pharma's Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal InfluenzaApril 23, 2024 | finance.yahoo.comCOCP: Topline Data for Influenza A and Dual Coronavirus/Norovirus Programs Expected in 2024; Model Revision Leads to Valuation of $6 Per Share…April 5, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Cocrystal Pharma (COCP) and Icecure Medical (ICCM)March 28, 2024 | msn.comCOCP Stock Earnings: Cocrystal Pharma Beats EPS for Q4 2023March 28, 2024 | finanznachrichten.deCocrystal Pharma, Inc.: Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development ProgramsMarch 28, 2024 | benzinga.comRecap: Cocrystal Pharma Q4 EarningsMarch 28, 2024 | globenewswire.comCocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development ProgramsMarch 20, 2024 | finanznachrichten.deCocrystal Pharma, Inc.: Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza AMarch 19, 2024 | markets.businessinsider.comCocrystal Pharma Receives Pre-IND Feedback Regarding CC-42344 - Quick FactsMarch 19, 2024 | globenewswire.comCocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza AFebruary 24, 2024 | investing.comCocrystal Pharma Inc (COCP)February 20, 2024 | finance.yahoo.comCOCP: Cocrystal Pharma provides updates on its clinical programs.February 11, 2024 | morningstar.comCocrystal Pharma Inc COCPJanuary 4, 2024 | finance.yahoo.comCocrystal Pharma Provides an Update on the Clinical Development of its Novel, Broad-Spectrum Antiviral Investigational CandidatesDecember 26, 2023 | benzinga.comCocrystal Pharma Stock (NASDAQ:COCP), Analyst Ratings, Price Targets, PredictionsDecember 26, 2023 | benzinga.comCocrystal Pharma Stock (NASDAQ:COCP) Dividends: History, Yield and DatesDecember 6, 2023 | finance.yahoo.comCocrystal Pharma Announces First-Patient-In for Phase 2a Human Challenge Study Evaluating Oral CC-42344 in Pandemic and Seasonal Influenza ANovember 29, 2023 | finance.yahoo.comCocrystal Pharma Highlights its Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West CoastNovember 27, 2023 | finance.yahoo.comCocrystal Pharma to Present at the NobleCon 19 Conference on December 4, 2023November 14, 2023 | benzinga.comCocrystal Pharma Stock (NASDAQ:COCP) Earnings Dates and Earning CallsNovember 14, 2023 | msn.comCOCP: Cocrystal Pharma reports 3rd quarter financial results and provides updates on clinical trials.November 13, 2023 | benzinga.comRecap: Cocrystal Pharma Q3 EarningsNovember 13, 2023 | finance.yahoo.comCocrystal Pharma Reports Third Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development ProgramsNovember 9, 2023 | finance.yahoo.comCocrystal Pharma to Discuss Progress with Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West CoastNovember 3, 2023 | markets.businessinsider.comBuy Rating Issued for Cocrystal Pharma Amid Advancements in Influenza and Coronavirus TreatmentsOctober 31, 2023 | finance.yahoo.comCocrystal Pharma Receives UK MHRA Authorization to Initiate Its Phase 2a Influenza Human Challenge Trial with Oral PB2 Inhibitor CC-42344October 5, 2023 | msn.comHC Wainwright & Co. Reiterates Cocrystal Pharma (COCP) Buy RecommendationOctober 2, 2023 | finance.yahoo.comCOCP: Cocrystal Pharma doses 1st subjects in the important CDI-988 clinical trial.August 16, 2023 | finance.yahoo.comCOCP: Cocrystal Pharma reports 2nd quarter 2023 financial results and provides updates on drug pipeline.August 15, 2023 | markets.businessinsider.comAnalyst Ratings for Cocrystal PharmaAugust 15, 2023 | markets.businessinsider.comCocrystal Pharma (COCP) Receives a Buy from H.C. WainwrightAugust 15, 2023 | markets.businessinsider.comNoble Financial Keeps Their Buy Rating on Cocrystal Pharma (COCP)August 14, 2023 | finance.yahoo.comCocrystal Pharma Reports Second Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development ProgramsAugust 11, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Immunocore Holdings (IMCR), Tyra Bioscience (TYRA)August 8, 2023 | finance.yahoo.comCocrystal Pharma Selects Novel Oral Protease Inhibitor CDI-988 as Norovirus LeadMay 31, 2023 | finance.yahoo.comCocrystal Pharma Receives HREC Approval to Initiate Phase 1 Study to Evaluate Oral Broad-Spectrum Coronavirus 3CL Protease Inhibitor CDI-988May 24, 2023 | msn.comHC Wainwright & Co. Maintains Cocrystal Pharma (COCP) Buy RecommendationMay 24, 2023 | markets.businessinsider.comH.C. Wainwright Keeps Their Buy Rating on Cocrystal Pharma (COCP)May 17, 2023 | finance.yahoo.comCOCP: Cocrystal Pharma reports 1st quarter 2023 financial results and provides updates on drug pipeline.May 15, 2023 | finance.yahoo.comCocrystal Pharma Reports First Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development ProgramsMay 4, 2023 | finance.yahoo.comCocrystal Pharma Presents New Data from its CC-42344 Phase 1 Influenza A Study at the 7th Annual ISIRV Antiviral Group ConferenceApril 24, 2023 | finance.yahoo.comCocrystal Pharma Appoints Pharma Industry Veteran Fred Hassan to its Board of DirectorsApril 18, 2023 | finance.yahoo.comCocrystal Pharma to Present New Data from its CC-42344 Phase 1 Influenza A Study at the 7th Annual ISIRV Antiviral Group ConferenceApril 12, 2023 | benzinga.comCocrystal Pharma Inc (COCP) Up 15.54% in Premarket TradingApril 10, 2023 | msn.comWhy Cocrystal Pharma Shares Are Trading Higher Today Get Cocrystal Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for COCP and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. COCP Media Mentions By Week COCP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COCP News Sentiment▼0.670.55▲Average Medical News Sentiment COCP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COCP Articles This Week▼100▲COCP Articles Average Week Get Cocrystal Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for COCP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: INDP News Today SLGL News Today AYTU News Today GLTO News Today KALA News Today VBIV News Today NRBO News Today BIVI News Today GLYC News Today SYBX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:COCP) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!Gold Safe ExchangeWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsWhy Is Gold On a MASSIVE rally? Huge AlertsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm PressHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cocrystal Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
